OPKO Health, Inc. Cost of Services (Deprecated 2018-01-31)
OPKO Health, Inc. (OPK) reported Cost of Services (Deprecated 2018-01-31) of $139.44 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfServices · last filed 2019-01-29
- OPKO Health, Inc. cost of services (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $139.44M, a 0.38% decline year-over-year.
- OPKO Health, Inc. cost of services (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $139.88M, a 4.83% decline year-over-year.
- OPKO Health, Inc. cost of services (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $135.20M, a 2.42% decline year-over-year.
- OPKO Health, Inc. cost of services (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $143.90M, a 2.08% increase year-over-year.
| Period end | Cost of Services (Deprecated 2018-01-31) 3 month | Cost of Services (Deprecated 2018-01-31) 6 month | Cost of Services (Deprecated 2018-01-31) 9 month | Cost of Services (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-03-31 | $139.44M 10-Q · filed 2018-05-08 | $279.32M derived: sum of 2 quarters · filed 2019-01-29 | $414.53M derived: sum of 3 quarters · filed 2019-01-29 | $558.43M derived: sum of 4 quarters · filed 2019-01-29 |
| 2017-12-31 | $139.88M derived: 8-K 12 month − 10-Q 9 month · filed 2019-01-29 | $275.09M derived: sum of 2 quarters · filed 2019-01-29 | $418.99M derived: sum of 3 quarters · filed 2019-01-29 | $558.95M 8-K · filed 2019-01-29 |
| 2017-09-30 | $135.20M 10-Q · filed 2017-11-08 | $279.10M derived: sum of 2 quarters · filed 2017-11-08 | $419.07M 10-Q · filed 2017-11-08 | $566.05M derived: sum of 4 quarters · filed 2019-01-29 |
| 2017-06-30 | $143.90M 10-Q · filed 2017-08-08 | $283.87M 10-Q · filed 2017-08-08 | $430.85M derived: sum of 3 quarters · filed 2019-01-29 | $569.40M derived: sum of 4 quarters · filed 2019-01-29 |
| 2017-03-31 | $139.97M 10-Q · filed 2018-05-08 | $286.95M derived: sum of 2 quarters · filed 2019-01-29 | $425.50M derived: sum of 3 quarters · filed 2019-01-29 | $566.47M derived: sum of 4 quarters · filed 2019-01-29 |
| 2016-12-31 | $146.98M derived: 8-K 12 month − 10-Q 9 month · filed 2019-01-29 | $285.54M derived: sum of 2 quarters · filed 2019-01-29 | $426.51M derived: sum of 3 quarters · filed 2019-01-29 | $564.10M 8-K · filed 2019-01-29 |
| 2016-09-30 | $138.55M 10-Q · filed 2017-11-08 | $279.52M derived: sum of 2 quarters · filed 2017-11-08 | $417.12M 10-Q · filed 2017-11-08 | $548.99M derived: sum of 4 quarters · filed 2019-01-29 |
| 2016-06-30 | $140.97M 10-Q · filed 2017-08-08 | $278.57M 10-Q · filed 2017-08-08 | $410.44M derived: sum of 3 quarters · filed 2019-01-29 | $467.11M derived: sum of 4 quarters · filed 2019-01-29 |
| 2016-03-31 | $137.60M 10-Q · filed 2017-05-10 | $269.47M derived: sum of 2 quarters · filed 2019-01-29 | $326.14M derived: sum of 3 quarters · filed 2019-01-29 | $328.64M derived: sum of 4 quarters · filed 2019-01-29 |
| 2015-12-31 | $131.87M derived: 8-K 12 month − 10-Q 9 month · filed 2019-01-29 | $188.54M derived: sum of 2 quarters · filed 2019-01-29 | $191.05M derived: sum of 3 quarters · filed 2019-01-29 | $193.31M 8-K · filed 2019-01-29 |
| 2015-09-30 | $56.67M 10-Q · filed 2016-11-07 | $59.17M derived: sum of 2 quarters · filed 2016-11-07 | $61.43M 10-Q · filed 2016-11-07 | |
| 2015-06-30 | $2.50M 10-Q · filed 2016-08-08 | $4.76M 10-Q · filed 2016-08-08 | ||
| 2015-03-31 | $2.26M 10-Q · filed 2016-05-09 | |||
| 2014-09-30 | $2.36M 10-Q · filed 2015-11-09 | $7.09M 10-Q · filed 2015-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |